Outlook Therapeutics (OTLK) Change in Accrued Expenses (2015 - 2026)
Outlook Therapeutics' Change in Accrued Expenses came in at -$5.76 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with $2.2 million a year earlier.
Powered by 
Analysis
Outlook Therapeutics (OTLK) Change in Accrued Expenses (2015 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Outlook Therapeutics reported Change in Accrued Expenses of -$1.31 million; for FY2025 (ended Sep 30, 2025), it came in at $1.71 million, up 247.8% from FY2024.
- Change in Accrued Expenses carries a five-year compound annual growth rate of 18.7% (FY2020 to FY2025).
- Going back by fiscal year, Change in Accrued Expenses was $491,728 in FY2024, -$711,661 in FY2023, $156,141 in FY2022 and -$5.3 million in FY2021.
- The fiscal Q3 2026 figure represents the lowest quarterly Change in Accrued Expenses in data going back to fiscal Q3 2015.
- Business Quant data shows OTLK's Change in Accrued Expenses at $4.39 million (Q2 2026), -$295,952 (Q1 2026) and $354,702 (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accrued Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 983.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -87.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 756.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Outlook Therapeutics | 62.90 Mn | 27.15 Mn | -8,265.00 | -5.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.76 Mn |
| Mar 31, 2026 | 4.39 Mn |
| Dec 31, 2025 | -295,952.00 |
| Sep 30, 2025 | 354,702.00 |
| Jun 30, 2025 | 2.20 Mn |
| Mar 31, 2025 | -994,707.00 |
| Dec 31, 2024 | 153,764.00 |
| Sep 30, 2024 | 556,554.00 |
| Jun 30, 2024 | -407,694.00 |
| Mar 31, 2024 | -998,162.00 |
| Dec 31, 2023 | 1.34 Mn |
| Sep 30, 2023 | -5.56 Mn |
| Jun 30, 2023 | 2.06 Mn |
| Mar 31, 2023 | -2.22 Mn |
| Dec 31, 2022 | 5.01 Mn |
| Sep 30, 2022 | -152,635.00 |
| Jun 30, 2022 | -515,379.00 |
| Mar 31, 2022 | -213,770.00 |
| Dec 31, 2021 | 1.04 Mn |
| Sep 30, 2021 | -1.77 Mn |
API Access
Outlook Therapeutics Change in Accrued Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();